Clinical Trials Browser

Phase 2 × Acetylcysteine × 30 days × Clear all

NCT04481048 2026-06-05

DoDNAC

Phase 2 Completed

25 enrolled 12 charts

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1

NCT07117630 2026-05-19

An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

Phase 2 Recruiting

Breast Neoplasms